How is the Inhibrx Biosciences Inc. today?

The Inhibrx Biosciences Inc. today is trading in the green, up by 1.67% at 14.57.

What is Inhibrx Biosciences Inc. Annual Revenue?

Inhibrx Biosciences Inc. Annual Revenue fell 88.89%, in the last year to $0.2 M. Its sector's average revenue growth for the last fiscal year was 57.71%.

What is Inhibrx Biosciences Inc. Annual Net Profit?

Inhibrx Biosciences Inc. Annual Net Profit rose 799.19% in the last year to $1,687.57 M. Its sector's average net profit growth for the last fiscal year was -28.42%.

What is Inhibrx Biosciences Inc. Price to Earning Ratio?

Inhibrx Biosciences Inc. Price to Earning Ratio is 0.12, lower than its sector PE ratio of 32.61.

What is Inhibrx Biosciences Inc. Stock Price?

Inhibrx Biosciences Inc. Stock Price rose 18.17% and underperformed its sector by 11.18% in the past year.

What is Inhibrx Biosciences Inc. Quarterly Net profit?

Inhibrx Biosciences Inc. Quarterly Net profit rose 44.97% YoY to $43.31 M. Its sector's average net profit growth YoY for the quarter was -20.03%.

What is Inhibrx Biosciences Inc. Debt to Equity Ratio?

Inhibrx Biosciences Inc. Debt to Equity Ratio of 0.06 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Inhibrx Biosciences Inc. Return on Equity(ROE)?

Inhibrx Biosciences Inc. Return on Equity(ROE) for the last financial year was 1,905.92%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

What is Inhibrx Biosciences Inc. Mutual Fund Holding?

Inhibrx Biosciences Inc. Mutual Fund Holding decreased by 0.21% in the last quarter to 19.08.

What is Inhibrx Biosciences Inc. Interest Coverage Ratio?

Inhibrx Biosciences Inc. Interest Coverage Ratio is 126.09, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Inhibrx Biosciences Inc. Institutional Holding?

Inhibrx Biosciences Inc. Institutional Holding increased by 1.31% in the last quarter to 76.78.

Inhibrx Biosciences Inc. XNAS: INXB

Inhibrx Biosciences Inc. Live Share Price Today, Share Analysis and Chart

Name: Inhibrx Biosciences Inc.: Is Infosys Ltd. worth buying?
Item: Inhibrx Biosciences Inc.
Rating: 1.20000
Author: Trendlyne DVM scores

about

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates inc...

14.57 0.24 (1.67%)

New 52W High in past week

52,259

XNAS Volume

XNAS 13 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Mid Valuation

43.0 / 100

Technically Bearish

5.0 / 100

No estimates available

Inhibrx Biosciences Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Inhibrx Biosciences Inc. FAQ

How is Inhibrx Biosciences Inc. today?

Inhibrx Biosciences Inc. today is trading in the green, and is up by 1.67% at 14.57.

How has Inhibrx Biosciences Inc. performed historically?

Inhibrx Biosciences Inc. is currently trading up 1.67% on an intraday basis. In the past week the stock rose 4.67%. stock has been up 18.17% in the past quarter and rose 18.17% in the past year. You can view this in the overview section.